| Cardio-cerebrovascular protective effects of valsartan in high-risk hypertensive patients with overweight/obesity: A post-hoc analysis of the KYOTO HEART Study. | |
| | |
MedLine Citation:
|
PMID: 22795716 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
PURPOSE: The objective was to examine whether baseline overweight/obesity influences the ARB, valsartan add-on effects on the cardio-cerebrovascular (CV) morbidity and mortality in the high-risk hypertensive patients who participated in the KYOTO HEART Study. METHODS AND RESULTS: The primary endpoint was the same as in the main study: a composite of defined CV events. Median follow-up period was 3.27years. According to the presence of overweight/obesity (body mass index≥25) at baseline, the study population was divided into two groups (with overweight/obesity; n=1177 and without overweight/obesity; n=1854), in which prevalence of primary endpoint events were similar in patients with overweight/obesity and patients without overweight/obesity (7.6% vs. 8.0%; HR 0.96, 95% CI 0.74-1.23). Valsartan add-on significantly decreased the occurrence of primary endpoint events in both overweight/obesity-positive patients (4.0% vs. 11.3%; HR 0.36, 95% CI 0.23-0.56) and overweight/obesity-negative patients (6.4% vs. 9.6%; HR 0.67, 95% CI 0.49-0.92) compared with non-ARB treatment. In the presence of overweight/obesity, the patients with valsartan add-on treatment had significantly smaller prevalence of new occurrence or exacerbation of angina pectoris, stroke, and heart failure than those with non-ARB treatment, while valsartan add-on effects on angina, stroke, and heart failure were not significant in the absence of overweight/obesity. Changes in blood pressure during the follow-up period did not differ significantly among the study subgroups. CONCLUSIONS: High-risk hypertensive patients with overweight/obesity might obtain more CV benefits from valsartan add-on treatment, compared with patients without overweight/obesity. |
| | |
Authors:
|
Hidekazu Irie; Jun Shiraishi; Takahisa Sawada; Masahiro Koide; Hiroyuki Yamada; Hiroaki Matsubara; |
Related Documents
:
|
22242146 - Disrupted functional brain connectivity in partial epilepsy: a resting-state fmri study. 22770406 - Correlations between serum uric acid level and disease activity, intrathecal inflammati... 22166506 - Adjuvant laboratory marker of kawasaki disease; nt-pro-bnp or hs-crp? 22429356 - Role of oxidative stress in the clinical outcome of patients with multiple blunt trauma. 15172716 - S100b protein in carbon monoxide poisoning: a pilot study. 3336826 - Duodenogastrocolic reflux after colonic interposition measurement using scintigraphic m... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-7-12 |
Journal Detail:
|
Title: International journal of cardiology Volume: - ISSN: 1874-1754 ISO Abbreviation: - Publication Date: 2012 Jul |
Date Detail:
|
Created Date: 2012-7-16 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8200291 Medline TA: Int J Cardiol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Department of Cardiology, Kyoto First Red Cross Hospital, Honmachi, Higashiyama-ku, Kyoto 605-0981, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: "Polarizing" microplegia improves cardiac cycle efficiency after CABG for unstable angina.
Next Document: Left ventricular hypertrophy reduction and clinical events. A meta-regression analysis of 14 studies...